Innate defense regulator peptide 1018 protects against perinatal brain injury

Annals of Neurology

Volumn 75, Issue 3, 2014, Pages 395-410

  Bolouri, Hayde ^a   Sävman, Karin ^a   Wang, Wei ^a   Thomas, Anitha ^b   Maurer, Norbert ^b   Dullaghan, Edie ^b   Fjell, Christopher D ^c   Ek, C Joakim ^a   Hagberg, Henrik ^a,d   Hancock, Robert E W ^c   Brown, Kelly L ^a,c   Mallard, Carina ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Centre for Drug Research and Development   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INNATE DEFENSE REGULATOR PEPTIDE 1002; INNATE DEFENSE REGULATOR PEPTIDE 1018; INNATE DEFENSE REGULATOR PEPTIDE HH2; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NEUROPROTECTIVE AGENT; PEPTIDE; PROTEIN; PROTEIN TNFSF9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE CONTROL; GENE EXPRESSION; GRAY MATTER; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WHITE MATTER;

ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIMICROBIAL CATIONIC PEPTIDES; APOPTOSIS; BRAIN INJURIES; CEREBRAL CORTEX; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYPOXIA-ISCHEMIA, BRAIN; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MALE; MICE; MICROGLIA; NERVE FIBERS, MYELINATED; NERVE FIBERS, UNMYELINATED; NEUROPROTECTIVE AGENTS; PRIMARY CELL CULTURE; TISSUE DISTRIBUTION;

EID: 84897987522     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24087     Document Type: Article

References (79)

1. Marlow N, Wolke D, Bracewell MA, Samara M,. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 2005; 352: 9-19.
2. Dammann O, Leviton A,. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997; 42: 1-8.
3. Dean JM, van de Looij Y, Sizonenko SV, et al. Delayed cortical impairment following lipopolysaccharide exposure in preterm fetal sheep. Ann Neurol 2011; 70: 846-856.
4. Favrais G, van de Looij Y, Fleiss B, et al. Systemic inflammation disrupts the developmental program of white matter. Ann Neurol 2011; 70: 550-565.
5. Hagberg H, Gressens P, Mallard C,. Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults. Ann Neurol 2012; 71: 444-457.
6. Volpe JJ,. Neonatal encephalitis and white matter injury: more than just inflammation? Ann Neurol 2008; 64: 232-236.
7. Doverhag C, Hedtjarn M, Poirier F, et al. Galectin-3 contributes to neonatal hypoxic-ischemic brain injury. Neurobiol Dis 2010; 38: 36-46.
8. Hedtjarn M, Leverin AL, Eriksson K, et al. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 2002; 22: 5910-5919.
9. Svedin P, Hagberg H, Savman K, et al. Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci 2007; 27: 1511-1518.
10. Wang X, Svedin P, Nie C, et al. N-acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury. Ann Neurol 2007; 61: 263-271.
11. Wang X, Stridh L, Li W, et al. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J Immunol 2009; 183: 7471-7477.
12. Fox C, Dingman A, Derugin N, et al. Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 2005; 25: 1138-1149.
13. Faustino JV, Wang X, Johnson CE, et al. Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke. J Neurosci 2011; 3: 12992-13001.
14. Imai F, Suzuki H, Oda J, et al. Neuroprotective effect of exogenous microglia in global brain ischemia. J Cereb Blood Flow Metab 2007; 27: 488-500.
15. Lalancette-Hebert M, Gowing G, Simard A, et al. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 2007; 27: 2596-2605.
16. Nijnik A, Madera L, Ma S, et al. Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. J Immunol 2010; 184: 2539-2550.
17. Scott MG, Dullaghan E, Mookherjee N, et al. An anti-infective peptide that selectively modulates the innate immune response. Nat Biotechnol 2007; 25: 465-472.
18. Wieczorek M, Jenssen H, Kindrachuk J, et al. Structural studies of a peptide with immune modulating and direct antimicrobial activity. Chem Biol 2010; 17: 970-980.
19. Hancock RE, Nijnik A, Philpott DJ,. Modulating immunity as a therapy for bacterial infections. Nat Rev Microbiol 2012; 10: 243-254.
20. Kindrachuk J, Jenssen H, Elliott M, et al. A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity. Vaccine 2009; 27: 4662-4671.
21. Achtman AH, Pilat S, Law CW, et al. Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria. Sci Transl Med 2012; 4: 135ra64.
22. Craig A, Ling Luo N, Beardsley DJ, et al. Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human. Exp Neurol 2003; 181: 231-240.
23. Dean JM, Wang X, Kaindl AM, et al. Microglial MyD88 signaling regulates acute neuronal toxicity of LPS-stimulated microglia in vitro. Brain Behav Immun 2010; 24: 776-783.
24. Barsky A, Gardy JL, Hancock RE, Munzner T,. Cerebral: a Cytoscape plugin for layout of and interaction with biological networks using subcellular localization annotation. Bioinformatics 2007; 23: 1040-1042.
25. Smyth GK., Limma: linear models for microarray data. In:, Gentleman R, Carey V., Dudoit S., et al, eds. Bioinformatics and computational biology solutions using R and Bioconductor. New York, NY: Springer, 2005: 397-420.
26. Eklind S, Mallard C, Leverin AL, et al. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur J Neurosci 2001; 13: 1101-1106.
27. Drury PP, Bennet L, Gunn AJ,. Mechanisms of hypothermic neuroprotection. Semin Fetal Neonatal Med 2010; 15: 287-292.
28. Shankaran S, Pappas A, Laptook AR, et al. Outcomes of safety and effectiveness in a multicenter randomized, controlled trial of whole-body hypothermia for neonatal hypoxic-ischemic encephalopathy. Pediatrics 2008; 122: e791-e798.
29. Moscat J, Diaz-Meco MT,. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 2009; 137: 1001-1004.
30. Nijboer CH, Heijnen CJ, Groenendaal F, et al. A dual role of the NF-kappaB pathway in neonatal hypoxic-ischemic brain damage. Stroke 2008; 39: 2578-2586.
31. Into T, Inomata M, Niida S, et al. Regulation of MyD88 aggregation and the MyD88-dependent signaling pathway by sequestosome 1 and histone deacetylase 6. J Biol Chem 2010; 285: 35759-35769.
32. Fang XX, Jiang XL, Han XH, et al. Neuroprotection of interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK/STAT3, MAPK/ERK, and PI3K/AKT signaling pathways. Cell Mol Neurobiol 2013; 33: 241-251.
33. Takeda K, Clausen BE, Kaisho T, et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999; 10: 39-49.
34. Bona E, Andersson AL, Blomgren K, et al. Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatr Res 1999; 45: 500-509.
35. Hedtjarn M, Mallard C, Hagberg H,. Inflammatory gene profiling in the developing mouse brain after hypoxia-ischemia. J Cereb Blood Flow Metab 2004; 24: 1333-1351.
36. Cowell RM, Xu H, Parent JM, Silverstein FS,. Microglial expression of chemokine receptor CCR5 during rat forebrain development and after perinatal hypoxia-ischemia. J Neuroimmunol 2006; 173: 155-165.
37. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM,. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995; 81: 505-512.
38. Hwang H, Lee S, Lee WH, et al. Stimulation of glucocorticoid-induced tumor necrosis factor receptor family-related protein ligand (GITRL) induces inflammatory activation of microglia in culture. J Neurosci Res 2010; 88: 2188-2196.
39. Yeo YA, Martinez Gomez JM, Croxford JL, et al. CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species. J Neuroinflammation 2012; 9: 173.
40. Takata M, Nakagomi T, Kashiwamura S, et al. Glucocorticoid-induced TNF receptor-triggered T cells are key modulators for survival/death of neural stem/progenitor cells induced by ischemic stroke. Cell Death Differ 2012; 19: 756-767.
41. Kendall GS, Hristova M, Horn S, et al. TNF gene cluster deletion abolishes lipopolysaccharide-mediated sensitization of the neonatal brain to hypoxic ischemic insult. Lab Invest 2011; 91: 328-341.
42. Nijboer CH, Heijnen CJ, van der Kooij MA, et al. Targeting the p53 pathway to protect the neonatal ischemic brain. Ann Neurol 2011; 70: 255-264.
43. Edwards AD, Brocklehurst P, Gunn AJ, et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 2010; 340: c363.
44. Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005; 365: 663-670.
45. Ivacko J, Szaflarski J, Malinak C, et al. Hypoxic-ischemic injury induces monocyte chemoattractant protein-1 expression in neonatal rat brain. J Cereb Blood Flow Metab 1997; 17: 759-770.
46. Cowell RM, Xu H, Galasso JM, Silverstein FS,. Hypoxic-ischemic injury induces macrophage inflammatory protein-1alpha expression in immature rat brain. Stroke 2002; 33: 795-801.
47. Kanno M, Suzuki S, Fujiwara T, et al. Functional expression of CCL6 by rat microglia: a possible role of CCL6 in cell-cell communication. J Neuroimmunol 2005; 167: 72-80.
48. Imai S, Ikegami D, Yamashita A, et al. Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain. Brain 2013; 136: 828-843.
49. Toyomitsu E, Tsuda M, Yamashita T, et al. CCL2 promotes P2X4 receptor trafficking to the cell surface of microglia. Purinergic Signal 2012; 8: 301-310.
50. Mojsilovic-Petrovic J, Callaghan D, Cui H, et al. Hypoxia-inducible factor-1 (HIF-1) is involved in the regulation of hypoxia-stimulated expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) and MCP-5 (Ccl12) in astrocytes. J Neuroinflammation 2007; 4: 12.
51. Columba-Cabezas S, Serafini B, Ambrosini E, Aloisi F,. Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation. Brain Pathol 2003; 13: 38-51.
52. Losy J, Zaremba J, Skrobanski P,. CXCL1 (GRO-alpha) chemokine in acute ischaemic stroke patients. Folia Neuropathol 2005; 43: 97-102.
53. Szczucinski A, Kalinowska A, Losy J,. CXCL11 (interferon-inducible T-cell alpha chemoattractant) and interleukin-18 in relapsing-remitting multiple sclerosis patients treated with methylprednisolone. Eur Neurol 2007; 58: 228-232.
54. Hagberg H, Gilland E, Bona E, et al. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res 1996; 40: 603-609.
55. Savman K, Blennow M, Gustafson K, et al. Cytokine response in cerebrospinal fluid after birth asphyxia. Pediatr Res 1998; 43: 746-751.
56. Suzuki S, Tanaka K, Suzuki N,. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab 2009; 29: 464-479.
57. Covey MV, Loporchio D, Buono KD, Levison SW,. Opposite effect of inflammation on subventricular zone versus hippocampal precursors in brain injury. Ann Neurol 2011; 70: 616-626.
58. Trepicchio WL, Wang L, Bozza M, Dorner AJ,. IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB. J Immunol 1997; 159: 5661-5670.
59. Jurewicz A, Matysiak M, Andrzejak S, Selmaj K,. TRAIL-induced death of human adult oligodendrocytes is mediated by JNK pathway. Glia 15; 53: 158-166.
60. Huang Z, Song L, Wang C, et al. Hypoxia-ischemia upregulates TRAIL and TRAIL receptors in the immature rat brain. Dev Neurosci 2011; 33: 519-530.
61. Krumbholz M, Theil D, Derfuss T, et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 2005; 201: 195-200.
62. Kim HJ, Lee JS, Kim JD, et al. Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation. Proc Natl Acad Sci U S A 2012; 109: E13-E22.
63. Liauw J, Hoang S, Choi M, et al. Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J Cereb Blood Flow Metab 2008; 28: 1722-1732.
64. Dzietko M, Derugin N, Wendland MF, et al. Delayed VEGF treatment enhances angiogenesis and recovery after neonatal focal rodent stroke. Transl Stroke Res 2013; 4: 189-200.
65. Yonezawa T, Hattori S, Inagaki J, et al. Type IV collagen induces expression of thrombospondin-1 that is mediated by integrin alpha1beta1 in astrocytes. Glia 2010; 58: 755-767.
66. Zhu C, Wang X, Huang Z, et al. Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ 2007; 14: 775-784.
67. Srinivasula SM, Ahmad M, Ottilie S, et al. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J Biol Chem 1997; 272: 18542-18545.
68. Northington FJ, Chavez-Valdez R, Graham EM, et al. Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J Cereb Blood Flow Metab 2011; 31: 178-189.
69. Covey MV, Levison SW,. Leukemia inhibitory factor participates in the expansion of neural stem/progenitors after perinatal hypoxia/ischemia. Neuroscience 2007; 148: 501-509.
70. Oya S, Yoshikawa G, Takai K, et al. Attenuation of Notch signaling promotes the differentiation of neural progenitors into neurons in the hippocampal CA1 region after ischemic injury. Neuroscience 2009; 158: 683-692.
71. Borg NA, Wun KS, Kjer-Nielsen L, et al. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 2007; 448: 44-49.
72. Kobayashi H, Hosono O, Iwata S, et al. The tetraspanin CD9 is preferentially expressed on the human CD4(+)CD45RA+ naive T cell population and is involved in T cell activation. Clin Exp Immunol 2004; 137: 101-108.
73. Smith AM, Gibbons HM, Oldfield RL, et al. M-CSF increases proliferation and phagocytosis while modulating receptor and transcription factor expression in adult human microglia. J Neuroinflammation 2013; 10: 85.
74. Chen KY, Wu CC, Chang CF, et al. Suppression of Etk/Bmx protects against ischemic brain injury. Cell Transplant 2012; 21: 345-354.
75. Joberty G, Petersen C, Gao L, Macara IG,. The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nat Cell Biol 2000; 2: 531-539.
76. Khazaei MR, Puschel AW,. Phosphorylation of the par polarity complex protein Par3 at serine 962 is mediated by aurora a and regulates its function in neuronal polarity. J Biol Chem 2009; 284: 33571-33579.
77. Zhang H, Macara IG,. The polarity protein PAR-3 and TIAM1 cooperate in dendritic spine morphogenesis. Nat Cell Biol 2006; 8: 227-237.
78. Matsumori Y, Northington FJ, Hong SM, et al. Reduction of caspase-8 and -9 cleavage is associated with increased c-FLIP and increased binding of Apaf-1 and Hsp70 after neonatal hypoxic/ischemic injury in mice overexpressing Hsp70. Stroke 2006; 37: 507-512.
79. Khorooshi R, Owens T,. Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system. J Immunol 2010; 185: 1258-1264.